Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH), 21338-21339 [2010-9523]
Download as PDF
<![CDATA[
21338
Federal Register / Vol. 75, No. 78 / Friday, April 23, 2010 / Notices
Act to evaluate the hospital’s request for
a waiver.
Section 1138(a)(2)(A) of the Act states
that in granting a waiver, the Secretary
must determine that the waiver—(1) Is
expected to increase organ donations;
and (2) will ensure equitable treatment
of patients referred for transplants
within the service area served by the
designated OPO and within the service
area served by the OPO with which the
hospital seeks to enter into an
agreement under the waiver. In making
a waiver determination, section
1138(a)(2)(B) of the Act provides that
the Secretary may consider, among
other factors: (1) Cost-effectiveness; (2)
improvements in quality; (3) whether
there has been any change in a
hospital’s designated OPO due to the
changes made in definitions for
metropolitan statistical areas; and (4)
the length and continuity of a hospital’s
relationship with an OPO other than the
hospital’s designated OPO. Under
section 1138(a)(2)(D) of the Act, the
Secretary is required to publish a notice
of any waiver application received from
a hospital within 30 days of receiving
the application, and to offer interested
parties an opportunity to comment in
writing during the 60-day period
beginning on the publication date in the
Federal Register.
The criteria that the Secretary uses to
evaluate the waiver in these cases are
the same as those described above under
sections 1138(a)(2)(A) and (B) of the Act
and have been incorporated into the
regulations at § 486.308(e) and (f).
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
II. Waiver Request Procedures
In October 1995, we issued a Program
Memorandum (Transmittal No. A–95–
11) detailing the waiver process and
discussing the information hospitals
must provide in requesting a waiver. We
indicated that upon receipt of a waiver
request, we would publish a Federal
Register notice to solicit public
comments, as required by section
1138(a)(2)(D) of the Act.
According to these requirements, we
will review the request and comments
received. During the review process, we
may consult on an as-needed basis with
the Health Resources and Services
Administration’s Division of
Transplantation, the United Network for
Organ Sharing, and our regional offices.
If necessary, we may request additional
clarifying information from the applying
hospital or others. We will then make a
final determination on the waiver
request and notify the hospital and the
designated and requested OPOs.
VerDate Nov<24>2008
15:23 Apr 22, 2010
Jkt 220001
III. Hospital Waiver Requests
As permitted by § 486.308(e), the
following hospital has requested a
waiver in order to enter into an
agreement with an OPO other than the
OPO designated for the service area in
which the hospital is located:
Jennie Stuart Medical Center
(Medicare provider number 18–0051) of
Hopkinsville, Kentucky, is requesting a
waiver to work with: Kentucky Organ
Donor Affiliates, 106 E. Broadway,
Louisville, Kentucky 40202.
The Hospital’s Designated OPO is:
Tennessee Donor Services, 7015
Middlebrook Pike, Knoxville, Tennessee
37909.
(Catalog of Federal Domestic Assistance
Program No. 93.773, Medicare—Hospital
Insurance; Program No. 93.774, Medicare—
Supplementary Medical Insurance, and
Program No. 93.778, Medical Assistance
Program)
Dated: April 15, 2010.
Charlene Frizzera,
Acting Administrator, Centers for Medicare
& Medicaid Services.
[FR Doc. 2010–9504 Filed 4–22–10; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Subcommittee for Dose
Reconstruction Reviews (SDRR),
Advisory Board on Radiation and
Worker Health (ABRWH), National
Institute for Occupational Safety and
Health (NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting for the
aforementioned subcommittee:
Time and Date: 3 p.m.–5 p.m., May
10, 2010.
Teleconference: Audio Conference
Call via FTS Conferencing. The USA toll
free dial in number is 1–866–659–0537
with a pass code of 9933701.
Status: Open to the public, but
without a public comment period.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
PO 00000
Frm 00119
Fmt 4703
Sfmt 4703
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to CDC. NIOSH
implements this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
and will expire on August 3, 2011.
Purpose: The Advisory Board is
charged with (a) Providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class. The
Subcommittee for Dose Reconstruction
Reviews was established to aid the
Advisory Board in carrying out its duty
to advise the Secretary, HHS, on dose
reconstruction.
Matters to be Discussed: The agenda
for the Subcommittee meeting includes:
selection of individual radiation dose
reconstruction cases to be considered
for review by the Advisory Board.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot
attend, written comments may be
submitted. Any written comments
received will be provided at the meeting
and should be submitted to the contact
person below well in advance of the
meeting.
Contact Person for More Information:
Theodore Katz, Executive Secretary,
NIOSH, CDC, 1600 Clifton Road,
Mailstop E–20, Atlanta GA 30333,
Telephone (513) 533–6800, Toll Free 1
(800)CDC–INFO, E-mail ocas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
E:\FR\FM\23APN1.SGM
23APN1
Federal Register / Vol. 75, No. 78 / Friday, April 23, 2010 / Notices
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2010–9523 Filed 4–22–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Developing
Novel Diagnostic Tests To Improve
Surveillance for Antimicrobial
Resistant Pathogens, Funding
Opportunity Announcement (FOA)
CI10–002; Initial Review
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 8 a.m.–5 p.m., May 18,
2010 (Closed).
Place: Sheraton Gateway Hotel Atlanta
Airport, 1900 Clifton Road, Atlanta, GA
30337, Telephone: (770) 979–1100.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Developing Novel Diagnostic
Tests to Improve Surveillance for
Antimicrobial Resistant Pathogens, FOA
CI10–002.’’
Contact Person for More Information:
Gregory Anderson, M.S., M.P.H., Scientific
Review Officer, CDC, 1600 Clifton Road, NE.,
Mailstop E60, Atlanta, GA 30333, Telephone:
(404) 498–2293.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: April 19, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Dated: April 19, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Administration for Children and
Families
National Institute of Environmental
Health Sciences; Notice of Closed
Meeting
Notice of Meeting; National
Commission on Children and Disasters
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel; Clinical and Pediatric Loan
Repayment Research Review.
Date: May 13, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIEHS/National Institutes of Health,
Keystone, 530 Davis Drive, Research Triangle
Park, NC 27709, (Virtual Meeting).
Contact Person: Leroy Worth, PhD,
Scientific Review Administrator, Scientific
Review Branch, Division of Extramural
Research and Training, Nat. Institute of
Environmental Health Sciences, P.O. Box
12233, MD EC–30/Room 3171, Research
Triangle Park, NC 27709, (919) 541–0670,
worth@niehs.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: April 16, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–9454 Filed 4–22–10; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2010–9519 Filed 4–22–10; 8:45 am]
BILLING CODE 4163–18–P
VerDate Nov<24>2008
15:23 Apr 22, 2010
Jkt 220001
21339
PO 00000
Frm 00120
Fmt 4703
Sfmt 4703
AGENCY: Administration for Children
and Families, Department of Health and
Human Services.
ACTION: Notice of meeting.
DATES: The meeting will be held on
Tuesday, May 11, 2010, from 10:30 a.m.
to 3:30 p.m.
ADDRESSES: The meeting will be held at
the Administration for Children and
Families, 901 D Street, SW.,
Washington, DC 20024. To attend either
in person or via teleconference, please
register by 5 p.m. Eastern Time, May 5,
2010. To register, please e-mail
jacqueline.haye@acf.hhs.gov with
‘‘Meeting Registration’’ in the subject
line, or call (202) 205–9560. Registration
must include your name, affiliation, and
phone number. If you require a sign
language interpreter or other special
assistance, please call Jacqueline Haye
at (202) 205–9560 or e-mail
jacqueline.haye@acf.hhs.gov as soon as
possible and no later than 5 p.m.
Eastern Time, April 27, 2010.
Agenda: The Commission will
discuss: (1) Ad-hoc progress report on
recommendations; (2) reports of
Subcommittees; and (3) report on field
visit to Florida. Written comments may
be submitted electronically to
roberta.lavin@acf.hhs.gov with ‘‘Public
Comment’’ in the subject line. The
Commission recommends that you
include your name, mailing address and
an e-mail address or other contact
information in the body of your
comment. This ensures that you can be
identified as the submitter of the
comment, and it allows the Commission
to contact you if further information on
the substance of the comment is needed
or if your comment cannot be read due
to technical difficulties. The
Commission’s policy is that the
Commission will not edit your
comment, and any identifying or contact
information provided in the body of a
comment will be included as part of the
comment placed in the official record.
The Commission will provide an
opportunity for public comments during
the public meeting on May 11, 2010.
Those wishing to speak will be limited
to three minutes each; speakers are
encouraged to submit their remarks in
writing in advance to ensure their
comment is received in case there is
E:\FR\FM\23APN1.SGM
23APN1
]]>Agencies
[Federal Register Volume 75, Number 78 (Friday, April 23, 2010)]
[Notices]
[Pages 21338-21339]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-9523]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory
Board on Radiation and Worker Health (ABRWH), National Institute for
Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting for the
aforementioned subcommittee:
Time and Date: 3 p.m.-5 p.m., May 10, 2010.
Teleconference: Audio Conference Call via FTS Conferencing. The USA
toll free dial in number is 1-866-659-0537 with a pass code of 9933701.
Status: Open to the public, but without a public comment period.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines that have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule; advice on methods of dose reconstruction which have
also been promulgated by HHS as a final rule; advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program; and advice on
petitions to add classes of workers to the Special Exposure Cohort
(SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and will expire on August 3, 2011.
Purpose: The Advisory Board is charged with (a) Providing advice to
the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advise the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class. The Subcommittee
for Dose Reconstruction Reviews was established to aid the Advisory
Board in carrying out its duty to advise the Secretary, HHS, on dose
reconstruction.
Matters to be Discussed: The agenda for the Subcommittee meeting
includes: selection of individual radiation dose reconstruction cases
to be considered for review by the Advisory Board.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may be
submitted. Any written comments received will be provided at the
meeting and should be submitted to the contact person below well in
advance of the meeting.
Contact Person for More Information: Theodore Katz, Executive
Secretary, NIOSH, CDC, 1600 Clifton Road, Mailstop E-20, Atlanta GA
30333, Telephone (513) 533-6800, Toll Free 1 (800)CDC-INFO, E-mail
ocas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of
[[Page 21339]]
meetings and other committee management activities, for both CDC and
the Agency for Toxic Substances and Disease Registry.
Dated: April 19, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2010-9523 Filed 4-22-10; 8:45 am]
BILLING CODE 4163-18-P
